Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Nitric Oxide in Stroke-2
ISRCTN17654248Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- Jul 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of nitroglycerin in stroke (2 arms), sponsored by University of Nottingham. Primary endpoints: Feasibility of recruitment and Safety. Started Jul 2021; status: completed.
02
Drugs
nitroglycerin
03
Conditions
stroke
Beyond the preview
Go deeper on ISRCTN17654248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17654248.